IR BioSciences Holdings, Inc. (IRBS.OB) Subsidiary Announces IND Submission for Homspera® for the Treatment of Idiopathic Pulmonary Fibrosis
ImmuneRegen BioSciences, a development-stage biotechnology company and a wholly owned subsidiary of IR BioSciences Holdings, Inc. (IRBS.OB), announced the company’s…